Kewaunee Scientific Corporation (KEQU) to Acquire Nycom for $55M Base Price

What happened

Kewaunee Scientific agreed to acquire Nycom for an initial base price of $55M, subject to EBITDA, or earnings before interest, taxes, depreciation and amortization, and customary post-closing adjustments. The deal is expected to close in Q4 fiscal 2027, subject to customary conditions.

Confirmed

Global impact / market context

The acquisition would bring Nycom, a distribution and installation partner, into Kewaunee’s laboratory business. If completed, this could give Kewaunee greater control over how its products reach customers, while the adjusted purchase price and integration costs could affect cash available and future returns.

Analyst inference

The stated $55M is an initial base price, not necessarily the final amount. Part of the payment is deferred through a subordinated note, meaning debt repaid after certain other claims, while another part is paid in newly issued shares. EBITDA adjustments could change consideration, and issuing shares could dilute existing owners.

Confirmed

What to watch

1. Watch for confirmation that the deal closes in Q4 fiscal 2027, as planned; customary closing conditions remain, so the acquisition is not assured. Confirmed
2. Look for final consideration disclosures, including EBITDA adjustments to the base price and the amount of the subordinated note, which could change the cost and payment mix. Confirmed
3. After closing, Nycom’s founder is expected to join Kewaunee’s board; investors can assess whether integration supports the laboratory business without costs outweighing added sales. Analyst inference

Evidence

• Original source link unavailable